Re: PNAS

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Prev Message Back To Forum Threaded View Next Message

chicagoest

Rank: President [?]

Points: 1974 [?]

Votes: 20 Score: 3.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: PNAS

in response to

Re: PNAS

10-41

posted on Jan 01, 2021 08:16PM

10-41

Thank You for the article.

An extensive and comprehensive study - way beyond my scientific understanding - both Enzalutamide and Apabetalone are cited in the study. Reference 33 in the study refers to Betonmace and the planned Covid-19 trial is mentioned. This should certainly spotlight BET Inhibition as a therapy for the virus. I was unaware until reading this piece that males are more at risk for serious Covid complications. This study highlights BET Inhibition and should propel RVX-208 and ZEN-3694 from obscurity to the mainstream.